ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHRISTOPHER POTTER MD

Neurology

994

$197K

176
130 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$198
Average prescription price

Avg: $204

PAUL GINSBERG MD

Neurology

2,858

$310K

302
200 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$108
Average prescription price

Avg: $204

LARA FIX DO, PA

Neurology

842

$109K

129
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$129
Average prescription price

Avg: $204

RALPH GONZALEZ M.D.

Neurology

2,269

$777K

288
193 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$343
Average prescription price

Avg: $204

GARCIA DESOUSA MD

Neurology

2,176

$440K

335
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$202
Average prescription price

Avg: $204

MARK EMAS MD

Neurology

1,649

$349K

264
172 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$212
Average prescription price

Avg: $204

ANGELA SPENCER M.D.

Neurology

554

$108K

99
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

77%
prescriptions for brand name drugs

Avg: 27%

$194
Average prescription price

Avg: $204

GREGORY PIACENTE M.D.

Neurology

1,253

$766K

121
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$612
Average prescription price

Avg: $204

PATRICIA MYERS M.D.

Neurology

401

$46.8K

78
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$117
Average prescription price

Avg: $204

EDWIN WINGKUN MD

Neurology

1,344

$279K

175
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$207
Average prescription price

Avg: $204

MUHAMMAD ZAMAN KHAN M.D.

Neurology

2,157

$119K

324
224 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $204

DAVID ROSS M.D.

Neurology

1,519

$214K

126
41 are 65+

38%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 4%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$141
Average prescription price

Avg: $204

RICARDO GONZALEZ MD

Neurology

1,372

$489K

239
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$357
Average prescription price

Avg: $204

DAVID SHAW MD

Neurology

242

$26.8K

42
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$111
Average prescription price

Avg: $204

SYLVIA ZUNIGA-BARBONI M.D.

Neurology

1,477

$267K

253
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 27%

$180
Average prescription price

Avg: $204

DONALD NEGROSKI MD

Neurology

2,782

$2.22M

379
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 27%

$797
Average prescription price

Avg: $204

GEORGE DIAZ MD

Neurology

1,097

$171K

159
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$155
Average prescription price

Avg: $204

LUIS FIGUEROA MD

Neurology

3,558

$122K

251
185 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$34
Average prescription price

Avg: $204

WILLIAM SUNTER MD

Neurology

2,161

$662K

275
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 27%

$306
Average prescription price

Avg: $204

ANIKA GOEL MD

Neurology

637

$33.4K

125
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $204

JOSE GARCIA GUERRA M.D.

Neurology

1,478

$382K

242
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$258
Average prescription price

Avg: $204

PAUL WAND M.D.

Neurology

1,952

$517K

70
21 are 65+

80%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$265
Average prescription price

Avg: $204

ANTONIO MESA D.O.

Neurology

1,756

$107K

291
227 are 65+

32%
patients receiving schedule two controlled substances

Avg: 4%

34%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $204

MARIA CARMEN WILSON MD

Neurology

1,412

$106K

132
48 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $204

TONYA DITRAPANI STEPHENSON MD

Neurology

892

$234K

183
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$262
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank